DICOPP
Dead / Cancelled — Cancelled — Section 8 (as of 25 Oct 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87479296
- Registration number
- 5439724
- Mark type
- Stylized text
- Filed
- 07 Jun 2017
- Published for opposition
- 24 Oct 2017
- Registered
- 03 Apr 2018
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Cantex Pharmaceuticals, Inc., Weston, FL, US
- Cantex Pharmaceuticals, Inc., Weston, FL, US
- Cantex Pharmaceuticals, Inc., Weston, FL, US
Prosecution history
- 25 Oct 2024 — CANCELLED SEC. 8 (6-YR)
- 03 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 01 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Feb 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Feb 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jan 2018 — USE AMENDMENT FILED
- 05 Feb 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jan 2018 — TEAS STATEMENT OF USE RECEIVED
- 19 Dec 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2017 — PUBLISHED FOR OPPOSITION
- 04 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Sept 2017 — ASSIGNED TO EXAMINER